• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃旁路手术前糖尿病患者的C反应蛋白作为术后并发症的可能标志物

C-REACTIVE PROTEIN IN DIABETIC PATIENTS BEFORE GASTRIC BYPASS AS A POSSIBLE MARKER FOR POSTOPERATIVE COMPLICATION.

作者信息

Lins Daniel C, Campos Josemberg M, de Paula Patrícia S, Galvão-Neto Manoel, Pachu Eduardo, Cavalcanti Ney, Ferraz Álvaro A B

机构信息

Oswaldo Cruz Hospital, Faculty of Medical Sciences of Pernambuco, Brazil.

Federal University of Pernambuco, Recife, PE, Brazil.

出版信息

Arq Bras Cir Dig. 2015;28 Suppl 1(Suppl 1):11-4. doi: 10.1590/S0102-6720201500S100005.

DOI:10.1590/S0102-6720201500S100005
PMID:26537265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4795298/
Abstract

BACKGROUND

Obesity and type 2 diabetes mellitus are associated to inflammatory state, which can be set off by the adipose tissue, once it is a metabolically active organ that can cause a chronic mild inflammatory state.

AIM

To evaluate the correlation between preoperative C-reactive protein and postoperative complications risk in obese patients (grades II and III) after Roux-en-Y gastric bypass, with and without type 2 diabetes mellitus.

METHODS

Between 2008 and 2013 were analysed 209 patients (107 with diabetes), presenting body mass index >40 kg/m2 or >35 kg/m2 with comorbidities. During the postoperative period, two groups were evaluated: with and without complications. Preoperative ultra-sensitive C-reactive protein was measured by immunonephelometry method.

RESULTS

Complications occurred in seven patients (pulmonary thromboembolism, fistula, two cases of suture leak, pancreatitis, evisceration and upper digestive hemorrhage). No statistical significance was found regarding lipid profile and C-reactive protein between patients with and without type 2 diabetes mellitus. When compared to each other, both groups (with and without complications) presented with statistical significance regarding C-reactive protein level (7,2 mg/dl vs 3,7 mg/dl, p=0,016) and had similar weight loss percentage after 3, 6 and 12 months follow-up.

CONCLUSIONS

Preoperative C-reactive protein serum level was higher in the group which presented complications after Roux-en-Y gastric bypass when compared to the group without postoperative complications.

摘要

背景

肥胖和2型糖尿病与炎症状态相关,脂肪组织可引发这种炎症状态,因为它是一个具有代谢活性的器官,能够导致慢性轻度炎症状态。

目的

评估接受Roux-en-Y胃旁路手术的肥胖患者(II级和III级),无论有无2型糖尿病,术前C反应蛋白与术后并发症风险之间的相关性。

方法

分析2008年至2013年间的209例患者(107例患有糖尿病),这些患者体重指数>40kg/m2或>35kg/m2且伴有合并症。在术后期间,对两组进行评估:有并发症组和无并发症组。术前超敏C反应蛋白采用免疫比浊法测量。

结果

7例患者出现并发症(肺血栓栓塞、瘘管、2例缝合口漏、胰腺炎、脏器脱出和上消化道出血)。2型糖尿病患者和非2型糖尿病患者之间在血脂谱和C反应蛋白方面未发现统计学意义。两组(有并发症组和无并发症组)相互比较时,在C反应蛋白水平方面具有统计学意义(7.2mg/dl对3.7mg/dl,p=0.016),并且在3、6和12个月随访后体重减轻百分比相似。

结论

与无术后并发症的组相比,接受Roux-en-Y胃旁路手术后出现并发症的组术前血清C反应蛋白水平更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34d/4795298/3d98e458b47e/0102-6720-abcd-28-s1-00011-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34d/4795298/86a7ab37dd58/0102-6720-abcd-28-s1-00011-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34d/4795298/3d98e458b47e/0102-6720-abcd-28-s1-00011-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34d/4795298/86a7ab37dd58/0102-6720-abcd-28-s1-00011-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34d/4795298/3d98e458b47e/0102-6720-abcd-28-s1-00011-gf02.jpg

相似文献

1
C-REACTIVE PROTEIN IN DIABETIC PATIENTS BEFORE GASTRIC BYPASS AS A POSSIBLE MARKER FOR POSTOPERATIVE COMPLICATION.胃旁路手术前糖尿病患者的C反应蛋白作为术后并发症的可能标志物
Arq Bras Cir Dig. 2015;28 Suppl 1(Suppl 1):11-4. doi: 10.1590/S0102-6720201500S100005.
2
Laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy achieve comparable weight loss at 1 year.腹腔镜Roux-en-Y胃旁路术和袖状胃切除术在1年内实现的体重减轻效果相当。
Am Surg. 2012 Dec;78(12):1325-8.
3
Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.血清视黄醇结合蛋白4在肥胖症或肥胖相关的2型糖尿病中并未升高,但在胃旁路术后体脂相应减少后会降低。
Clin Endocrinol (Oxf). 2008 Aug;69(2):208-15. doi: 10.1111/j.1365-2265.2007.03156.x. Epub 2007 Dec 10.
4
Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.Roux-en-Y胃旁路手术治疗病态肥胖及控制2型糖尿病后的激素变化。
Am Surg. 2004 Jan;70(1):1-4; discussion 4-5.
5
Preoperative hemoglobin A1c and postoperative glucose control in outcomes after gastric bypass for obesity.肥胖患者行胃旁路术后血红蛋白 A1c 术前水平与术后血糖控制对结局的影响。
Surg Obes Relat Dis. 2012 Nov-Dec;8(6):685-90. doi: 10.1016/j.soard.2011.08.002. Epub 2011 Aug 10.
6
Laparoscopic gastric bypass: risks vs. benefits up to two years following surgery in super-super obese patients.腹腔镜胃旁路手术:超级肥胖患者术后两年的风险与益处
Surgery. 2006 Oct;140(4):524-9; discussion 529-31. doi: 10.1016/j.surg.2006.07.002.
7
[Laparoscopic Roux-en-Y gastric bypass surgery for morbid obesity. Experience at the Nacional de Ciencias Médicas y Nutrición Salvador Zubirán].[腹腔镜Roux-en-Y胃旁路手术治疗病态肥胖症。萨尔瓦多·苏比拉án国家医学与营养科学研究所的经验]
Rev Invest Clin. 2009 May-Jun;61(3):186-93.
8
Laparoscopic Roux-en-Y gastric bypass for treatment of symptomatic paraesophageal hernia in the morbidly obese: medium-term results.腹腔镜Roux-en-Y胃旁路术治疗病态肥胖患者的症状性食管旁疝:中期结果
Surg Obes Relat Dis. 2014 Nov-Dec;10(6):1063-7. doi: 10.1016/j.soard.2014.02.004. Epub 2014 Feb 10.
9
Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial.胃旁路手术患者术前体重减轻有好处吗?一项前瞻性随机试验。
Surg Obes Relat Dis. 2007 Mar-Apr;3(2):141-5; discussion 145-6. doi: 10.1016/j.soard.2006.11.006. Epub 2007 Feb 27.
10
Incidence of deep vein thrombosis in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass.接受腹腔镜Roux-en-Y胃旁路手术的病态肥胖患者深静脉血栓形成的发生率。
Surg Obes Relat Dis. 2008 Mar-Apr;4(2):126-30. doi: 10.1016/j.soard.2007.12.015.

引用本文的文献

1
Cumulative Incidence of Venous Thromboembolic Events In-Hospital, and at 1, 3, 6, and 12 Months After Metabolic and Bariatric Surgery: Systematic Review of 87 Studies and Meta-analysis of 2,731,797 Patients.代谢和减重手术后住院期间、1 个月、3 个月、6 个月和 12 个月时静脉血栓栓塞事件的累积发生率:87 项研究的系统评价和 2731797 例患者的荟萃分析。
Obes Surg. 2024 Jun;34(6):2154-2176. doi: 10.1007/s11695-024-07184-7. Epub 2024 Apr 11.
2
WEIGHT LOSS COMPARISON AFTER SLEEVE AND ROUX-EN-Y GASTRIC BYPASS: SYSTEMATIC REVIEW.袖状胃切除术和Roux-en-Y胃旁路术后体重减轻比较:系统评价
Arq Bras Cir Dig. 2019 Dec 20;32(4):e1474. doi: 10.1590/0102-672020190001e1474. eCollection 2019.
3

本文引用的文献

1
Should we wait for metabolic complications before operating on obese patients? Gastric bypass outcomes in metabolically healthy obese individuals.我们是否应该在肥胖患者出现代谢并发症后再进行手术?代谢健康的肥胖个体的胃旁路手术结果。
Surg Obes Relat Dis. 2016 Jan;12(1):49-56. doi: 10.1016/j.soard.2015.04.024. Epub 2015 May 8.
2
Meta-analysis of the predictive value of C-reactive protein for infectious complications in abdominal surgery.C-反应蛋白对腹部手术感染性并发症预测价值的荟萃分析。
Br J Surg. 2015 May;102(6):590-8. doi: 10.1002/bjs.9756. Epub 2015 Mar 16.
3
Diagnostic markers of postoperative morbidity after laparoscopic Roux-en-Y gastric bypass for obesity.
IMPACT OF BARIATRIC SURGERY ON THE INFLAMMATORY STATE BASED ON CPR VALUE.
基于心肺复苏值的减重手术对炎症状态的影响。
Arq Bras Cir Dig. 2018 Dec 6;31(4):e1402. doi: 10.1590/0102-672020180001e1402.
4
PRE- AND POSTOPERATIVE IN BARIATRIC SURGERY: SOME BIOCHEMICAL CHANGES.减肥手术的术前与术后:一些生化变化
Arq Bras Cir Dig. 2016;29Suppl 1(Suppl 1):67-71. doi: 10.1590/0102-6720201600S10017.
腹腔镜Roux-en-Y胃旁路术治疗肥胖症后术后并发症的诊断标志物。
Langenbecks Arch Surg. 2014 Apr;399(4):503-8. doi: 10.1007/s00423-014-1180-z. Epub 2014 Mar 19.
4
Effect of bariatric surgery on weight loss, inflammation, iron metabolism, and lipid profile.减重手术对体重减轻、炎症、铁代谢和血脂谱的影响。
Scand J Surg. 2014 Mar;103(1):21-5. doi: 10.1177/1457496913490467. Epub 2013 Oct 31.
5
Managing complications associated with laparoscopic Roux-en-Y gastric bypass for morbid obesity.腹腔镜 Roux-en-Y 胃旁路术治疗病态肥胖相关并发症的管理。
Can J Surg. 2012 Oct;55(5):329-36. doi: 10.1503/cjs.002011.
6
Safe and early discharge after colorectal surgery due to C-reactive protein: a diagnostic meta-analysis of 1832 patients.结直肠手术后基于 C 反应蛋白的安全及早出院:1832 例患者的诊断性荟萃分析。
Ann Surg. 2012 Aug;256(2):245-50. doi: 10.1097/SLA.0b013e31825b60f0.
7
C-reactive protein 2 days after laparoscopic gastric bypass surgery reliably indicates leaks and moderately predicts morbidity.腹腔镜胃旁路手术后 2 天的 C 反应蛋白可靠地表明存在漏液,并适度预测发病率。
J Gastrointest Surg. 2012 Jun;16(6):1128-35. doi: 10.1007/s11605-012-1882-x. Epub 2012 Apr 13.
8
Gastrobronchial fistula after sleeve gastrectomy and gastric bypass: endoscopic management and prevention.袖状胃切除术和胃旁路术后胃支气管瘘:内镜治疗和预防。
Obes Surg. 2011 Oct;21(10):1520-9. doi: 10.1007/s11695-011-0444-8.
9
How to manage type 2 diabetes in medical and surgical patients in the hospital.如何在医院的内科和外科患者中管理 2 型糖尿病。
Cleve Clin J Med. 2011 Jun;78(6):379-84. doi: 10.3949/ccjm.78gr.11001.
10
Prediction of severe complications and death in superobese patients undergoing open gastric bypass with the Recife Score.使用累西腓评分预测接受开放式胃旁路手术的超级肥胖患者的严重并发症和死亡情况。
Arq Gastroenterol. 2011 Jan-Mar;48(1):8-14. doi: 10.1590/s0004-28032011000100003.